"Darwin’s Database”
Abstract:
School of Research
Short Code:
SoR
"MASSIVELY PARALLEL FLUORESCENCE LIFETIME IMAGING MICROSCOPY TO INVESTIGATE CELLULAR DYNAMICS"
“Actinomycetes from extreme environments – methods to accelerate antibiotic discovery”
“Synthesis in the Chemical Space Age”
Researchers shine a light into the mechanisms of potato late blight infection
Scientists at the James Hutton Institute, in collaboration with colleagues in the School of Life Sciences, University of Dundee, Huazhong Agricultural University, Heilongjiang Academy of Agricultural Sciences (both China) and Wageningen University (Netherlands), have shed further light into the mechanisms through which the potato blight pathogen interacts with plant cells to promote disease.
Scientists overturn odds to make Parkinson’s discovery
Scientists in the School have confirmed that a key cellular pathway that protects the brain from damage is disrupted in Parkinson’s patients, raising the possibility of new treatments for the disease. Parkinson’s is a disabling disorder of the brain for which there is no cure. Mutations in two genes called PINK1 and Parkin are associated with early-onset forms of Parkinson’s. Both encode distinct classes of enzymes that play a pivotal role in protecting the brain against stress.
‘The impact of macrophage phagocytosis in the modulation of inflammation resolution’
Abstract:
“From Penicillins to Epigenetics – Adventures at the Interface of Chemistry and Biology”
PhD students take part in entrepreneurial competition Biotechnology YES
PhD students from the MRC PPU took part in the Biotechnology YES 2018 entrepreneurial competition last week. Luke Fulcher (Sapkota lab), Lambert Montava Garriga (Ganley lab), Maria Zachari (Ganley lab) and Marianna Longo (Ganley lab) formed the team “AllerTek” which sought to combat the presence of food allergens in meals.
The biotechnology YES competition allows PhD students from across the UK to compete against each other with their ideas in a “dragons den” style pitch to secure theoretical funding for their innovation.
20th anniversary of the Division of Signal Transduction Therapy to be celebrated
The success of a University of Dundee collaboration that has attracted almost £60 million of investment, helped develop dozens of drugs for clinical use and won the prestigious Queen’s Anniversary Award will be celebrated this week. Scientists, politicians and representatives of some of the world’s biggest pharmaceutical companies will come together to mark the 20th anniversary of the University of Dundee’s Division of Signal Transduction Therapy (DSTT).